No Data
No Data
Supernus Pharmaceuticals | 10-Q: Quarterly report
Express News | Supernus Pharmaceuticals Sees FY24 Total Revenue $630M-$650M Vs $619.505M Est
Supernus Pharmaceuticals Q3 2024 GAAP EPS $0.69 Beats $0.02 Estimate, Sales $175.689M Beat $157.298M Estimate
Express News | Supernus Pharmaceuticals Q3 Operating Earnings USD 40.845 Million
Supernus Pharmaceuticals 3Q Net $38.5M >SUPN
Press Release: Supernus Announces Third Quarter 2024 Financial Results